Page last updated: 2024-11-07

idoxuridine and Blast Crisis

idoxuridine has been researched along with Blast Crisis in 2 studies

Blast Crisis: An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%.

Research Excerpts

ExcerptRelevanceReference
"Also in acute myeloid leukemia (AML), the proliferation rate (percentage S/G(2)+M and Iododeoxyuridine labelings index) was significantly less in the RhoD blasts (P 1.30Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance. ( de Witte, T; Pennings, AH; Raymakers, RA; Smeets, ME; Vierwinden, G; Wessels, H, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hegde, U1
Kotelnikov, VM1
Handa, H1
Burke, P1
Preisler, HD1
Smeets, ME1
Raymakers, RA1
Vierwinden, G1
Pennings, AH1
Wessels, H1
de Witte, T1

Other Studies

2 other studies available for idoxuridine and Blast Crisis

ArticleYear
Accuracy of immunohistochemistry and flow cytometry in estimating the proportion of leukemic cells in S phase in chronic myeloid leukemia patients.
    Leukemia & lymphoma, 1996, Volume: 22, Issue:5-6

    Topics: Antibodies, Monoclonal; Biopsy, Needle; Blast Crisis; Bone Marrow; Cell Division; Flow Cytometry; Fl

1996
Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance.
    Blood, 1999, Oct-01, Volume: 94, Issue:7

    Topics: Antibiotics, Antineoplastic; Antigens, CD34; ATP Binding Cassette Transporter, Subfamily B, Member 1

1999